New York—September 26, 2013
Update: Full event video now available online. Watch now.
As part of Hospital for Special Surgery’s 150th anniversary celebration, the Division of Rheumatology honored the thousands of lupus patients, past and present, who have inspired each member of the HSS healthcare team. “Honoring Lupus Heroes” celebrated patients’ wisdom, generosity and invaluable contributions to lupus research and care. “We are deeply grateful that they have allowed us to learn from their journey and grow as caregivers,” HSS physician-in-chief Dr. Peggy Crow said at the event on September 24.
“Our patients are the unsung heroes who have helped transform lupus care,” said Dr. Jane E. Salmon, Director of the Lupus and Antiphospholipid Syndrome Center of Excellence at Hospital for Special Surgery (HSS) at the event. “They donate blood and tissue samples for research, take investigational drugs in clinical trials, and provide personal insights to improve how we care for them and for others. They are philanthropic and volunteer as peer counselors. They sacrifice time, energy, personal resources and their own privacy to advance science and clinical care.”
An auto-immune disease that can impact the joints, skin, kidneys, heart and other organs, lupus affects more than 600,000 people in the United States. HSS is internationally known for research into the disease and treats one of the world’s largest populations of lupus patients.
“When I started out as a physician many years ago, the average survival rate was around three years. Today it is rare to lose a patient to lupus,” said HSS rheumatologist Dr. Michael Lockshin. “Advances in lupus treatment have transformed it from a fatal disease to a chronic illness, enabling many people to lead normal lives. What makes these people heroes are that they are willing to be a part of this and help us do our job better.”
One such patient is Rachel Grodzinsky, among the first to participate in a study at HSS which challenged the widely-held belief that women with lupus should not become pregnant.
“I felt somewhat honored to be a part of it. I felt it was really important,” she recalled. “Pregnancy was something I had been struggling with for a few years before I actually got into the study. It felt very dear to me because it was something that I felt would help others.”
Ms. Grodzinsky later became the proud mother of two sons.
Marielin Lopez was initially treated at HSS 13 years ago. She was moved to tears as she described how the HSS team helped her get through difficult times. She is now a bilingual volunteer and health educator at HSS, focusing on underserved families and adolescents living with the disease.
“I am very passionate about empowering people and making a difference in their lives, especially Latinos living with lupus,” she explained. “For me, the most effective medication and Lupus cure has been experiencing the joy, fulfillment and health benefits of sharing my story and being there for them.”
Another HSS patient, Karen Ng, cited the importance of helping other Lupus patients, particularly members of her Asian American community. After she was diagnosed with lupus, she discovered that there were few resources available for patients like her.
Ms. Ng helped launch the LANtern® Lupus Asian Network at HSS, the only national hospital-based bilingual support and education program dedicated to serving Asian Americans with lupus and their families.
“Our mission is to support, empower, and enhance the quality of life of Asian Americans with lupus and their families through our bilingual peer health education program,” Ms. Ng explained. “Our goal is to bring hope and provide enlightenment concerning this complex illness.”
At the event, Dr. Lockshin presented an historical timeline of lupus and HSS, including important milestones representing significant breakthroughs in research and treatment. Several lupus patients and their family members reflected on their experiences at Hospital for Special Surgery and how they were inspired to make a difference in the lives of other patients. In addition, HSS team members—including physicians, nurses, social workers and others—paid tribute to specific “Lupus Heroes.”
Monica Richey, RN, nurse practitioner for the Lupus Center of Excellence, talked movingly about how HSS patients have inspired her every single day with their courage, humor and what she described as “the power of persistence.”
She shared a quote which she believes exemplifies the spirit of the “Lupus Heroes:” “Persistence is what makes the impossible possible, the possible likely and the likely definite.”
At the conclusion of the event, HSS physician-in-chief Dr. Peggy Crow unveiled a plaque honoring the heroic lupus pioneers and all of the HSS patients who continue to help advance the field.
“Our ‘Lupus Heroes’ are extraordinary people whose contributions have helped improve the lives of thousands of individuals with the disease,” said Dr. Crow. “They have taught us poignant lessons about compassion, service and excellence in care. We are deeply grateful that they have allowed us to learn from their journey and grow as caregivers, and we’re thrilled to have this opportunity to honor them.”
A Lupus Chat will take place on the HSS Facebook page (Facebook.com/hspecialsurgery) on November 6 from 5:30 to 6:30 p.m. EDT. Physicians will be on hand to answer any questions patients may have regarding the disease.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics for 14 years in a row and No. 2 in rheumatology by U.S.News & World Report (2023-2024). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In addition, HSS opened a new facility in Florida in early 2020. In 2019, HSS provided care to 151,000 patients and performed more than 35,000 surgical procedures, and people from all 50 U.S. states and 89 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 translational research laboratories, 33 scientists, 10 clinician-scientists, 55 clinical investigators and 245 scientific support staff that drive the HSS research enterprise in the musculoskeletal “ecosystem,” neurology, pain management and rheumatic diseases. The HSS Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is the world’s leading provider of education on musculoskeletal health, with its online learning platform offering more than 300 courses to more than 30,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.
212.606.1197
mediarelations@hss.edu